相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Two Sides of the Same Coin-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
Mona Khoury et al.
PHARMACEUTICS (2022)
Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post-hoc Analysis of NMS-Nab Study
Marina Peball et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2022)
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
Alessia Furgiuele et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)
Toxicological aspects of cannabinoid, pesticide and metal levels detected in light Cannabis inflorescences grown in Italy
G. Amendola et al.
FOOD AND CHEMICAL TOXICOLOGY (2021)
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4
Tengfei Huang et al.
AUTOPHAGY (2021)
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma
Chris Twelves et al.
BRITISH JOURNAL OF CANCER (2021)
Delta9-THC determination by the EU official method: evaluation of measurement uncertainty and compliance assessment of hemp samples
Salvatore Sgro et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial
Timna Naftali et al.
JOURNAL OF CROHNS & COLITIS (2021)
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Anna Campanati et al.
BIOMEDICINES (2021)
The Molecular Pathophysiology of Psoriatic Arthritis-The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome
Ana L. Carvalho et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
Anup D. Patel et al.
EPILEPSIA (2021)
The Role of Epigenetic Factors in Psoriasis
Klaudia Dopytalska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabis and Autoimmunity: Possible Mechanisms of Action
Valeria Giorgi et al.
IMMUNOTARGETS AND THERAPY (2021)
Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice
Leah M. Mayo et al.
MOLECULAR PSYCHIATRY (2020)
Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients
Sidra Saleem et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial
Leah M. Mayo et al.
BIOLOGICAL PSYCHIATRY (2020)
Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption
Mauricio dos-Santos-Pereira et al.
GLIA (2020)
The potential role of cannabinoids in dermatology
Tabrez Sheriff et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2020)
Endocannabinoid system and adult neurogenesis: a focused review
Sergio Oddi et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer
A. Fraguas-Sanchez et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Cannabinoids in the Pathophysiology of Skin Inflammation
Cristian Scheau et al.
MOLECULES (2020)
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
Lara Milian et al.
PLOS ONE (2020)
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay et al.
ANTIOXIDANTS (2020)
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Melanie Kienzl et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martinez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies
A. Fraguas-Sanchez et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Edward Chesney et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Systemic Lupus Erythematosus
Marianthi Kiriakidou et al.
ANNALS OF INTERNAL MEDICINE (2020)
Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells
Recardia Schoeman et al.
MOLECULES (2020)
Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
Torsten Lowin et al.
CELL DEATH & DISEASE (2020)
Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
Zackary Montoya et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Gil Bar-Sela et al.
CANCERS (2020)
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
Felipe Patricio et al.
FRONTIERS IN PHARMACOLOGY (2020)
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
Maureen A. Leehey et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Immune Responses Regulated by Cannabidiol
James M. Nichols et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
Alyssa S. Laun et al.
ACTA PHARMACOLOGICA SINICA (2019)
Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity
Abdella M. Habib et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial
Daniel G. Couch et al.
INFLAMMATORY BOWEL DISEASES (2019)
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus Endophenotype
Oindrila Rahaman et al.
JOURNAL OF IMMUNOLOGY (2019)
Effects of cannabidiol in males and females in two different rat models of depression
Liat Shbiro et al.
PHYSIOLOGY & BEHAVIOR (2019)
Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
James W. Wheless et al.
CNS DRUGS (2019)
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis
Torsten Lowin et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro et al.
MOLECULES (2019)
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor
Rangel L. Silva et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists
Joseph E. Henriquez et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
Jung Lim Kim et al.
CANCERS (2019)
Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors
Carlos Henrique Alves Jesus et al.
BRAIN RESEARCH (2019)
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco et al.
DRUGS (2019)
Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2019)
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2019)
Novel paradigms in systemic lupus erythematosus
Thomas Doerner et al.
LANCET (2019)
Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures
Mark Mascal et al.
SCIENTIFIC REPORTS (2019)
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study
Oliver Hendricks et al.
BMJ OPEN (2019)
Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3-and SOD2-Induced Autophagy in Human Colorectal Cancer Cells
Soyeon Jeong et al.
CANCERS (2019)
Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model
Chen Xu et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2019)
Molecular mechanism of TRPV2 channel modulation by cannabidiol
Ruth A. Pumroy et al.
ELIFE (2019)
Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
Anna Jastrzab et al.
CELLS (2019)
Synthetic Strategies for (-)-Cannabidiol and Its Structural Analogs
Byunghyuck Jung et al.
CHEMISTRY-AN ASIAN JOURNAL (2019)
Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer
Soyeon Jeong et al.
CELL DEATH & DISEASE (2019)
Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes
Jeffrey W. Chen et al.
ANNALS OF PHARMACOTHERAPY (2019)
Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells
Soyeon Jeong et al.
CANCER LETTERS (2019)
Systemic lupus erythematosus: Diagnosis and clinical management
Andrea Fava et al.
JOURNAL OF AUTOIMMUNITY (2019)
Cannabis, Cannabinoids, and the Endocannabinoid SystemIs there Therapeutic Potential for Inflammatory Bowel Disease?
Tim Ambrose et al.
JOURNAL OF CROHNS & COLITIS (2019)
Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats
Murat Cakir et al.
LIFE SCIENCES (2019)
Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
Kerstin A. Klotz et al.
FRONTIERS IN NEUROLOGY (2019)
HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β
James T. Wilson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis
Peter M. Irving et al.
INFLAMMATORY BOWEL DISEASES (2018)
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism
Luca Navarini et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Quality Traits of Cannabidiol Oils: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations
Radmila Pavlovic et al.
MOLECULES (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Regulation of Adipose Tissue Metabolism by the Endocannabinoid System
Robin van Eenige et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
G. M. Mandolini et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2018)
Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin
Nicola Maggio et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Fernanda F. Peres et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide
Israel Lopez-Valero et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors
Andreza B. Sonego et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
Uchini S. Kosgodage et al.
FRONTIERS IN PHARMACOLOGY (2018)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
DRUGS (2018)
Diagnosis and Management of Rheumatoid Arthritis A Review
Daniel Aletaha et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Federica Pellati et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
Fabricio A. Pamplona et al.
FRONTIERS IN NEUROLOGY (2018)
The endocannabinoid system in cardiovascular function: novel insights and clinical implications
Salvador Sierra et al.
CLINICAL AUTONOMIC RESEARCH (2018)
Long-term stability of cannabinoids in oral fluid after controlled cannabis administration
Karl B. Scheidweiler et al.
DRUG TESTING AND ANALYSIS (2017)
Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy
Madeline C. Pelz et al.
EPILEPSY & BEHAVIOR (2017)
Cannabis: Exercise performance and sport. A systematic review
Michael C. Kennedy
JOURNAL OF SCIENCE AND MEDICINE IN SPORT (2017)
Novel treatment strategies in rheumatoid arthritis
Gerd R. Burmester et al.
LANCET (2017)
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation
Amir Hossein Norooznezhad et al.
MEDICAL HYPOTHESES (2017)
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
Marta Kruk-Slomka et al.
NEUROTOXICITY RESEARCH (2017)
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Zewen Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
Marco Aurelio Mori et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
Yulan Liu et al.
NUTRIENTS (2017)
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Carina Hasenoehrl et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2017)
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Georgia Watt et al.
FRONTIERS IN PHARMACOLOGY (2017)
A selective review of medical cannabis in cancer pain management
Alexia Blake et al.
ANNALS OF PALLIATIVE MEDICINE (2017)
Cannabidiol, a novel inverse agonist for GPR12
Kevin J. Brown et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon
Daniel G. Couch et al.
CLINICAL SCIENCE (2017)
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
Alexandre Vallee et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
GPR3 and GPR6, novel molecular targets for cannabidiol
Alyssa S. Laun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial
Timna Naftali et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
Gillian M. Keating
DRUGS (2017)
Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture
Liting Deng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Cannabinoids and autoimmune diseases: A systematic review
Valeria Katchan et al.
AUTOIMMUNITY REVIEWS (2016)
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors
A. G. Sartim et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice
Andreza B. Sonego et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
Sindiswa T. Lukhele et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPAR and 5-HT1A receptors
William H. Hind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome
Stephanie E. Reuter et al.
CLINICAL PHARMACOKINETICS (2016)
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
Thangavelu Soundara Rajan et al.
FITOTERAPIA (2016)
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
Regina M. Krohn et al.
JOURNAL OF INFLAMMATION-LONDON (2016)
The clinical symptoms of Parkinson's disease
Sigurlaug Sveinbjornsdottir
JOURNAL OF NEUROCHEMISTRY (2016)
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
Ewa Kozela et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Ageing, neurodegeneration and brain rejuvenation
Tony Wyss-Coray
NATURE (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Type-2 cannabinoid receptors in neurodegeneration
Tiziana Bisogno et al.
PHARMACOLOGICAL RESEARCH (2016)
Cannabidiol, neuroprotection and neuropsychiatric disorders
Alline C. Campos et al.
PHARMACOLOGICAL RESEARCH (2016)
How neuroinflammation contributes to neurodegeneration
Richard M. Ransohoff
SCIENCE (2016)
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
Massimo Nabissi et al.
ONCOTARGET (2016)
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemcally-induced Intestinal Inflammation and Hypermotility in the Mouse
Ester Pagano et al.
FRONTIERS IN PHARMACOLOGY (2016)
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
Fernanda F. Peres et al.
FRONTIERS IN PHARMACOLOGY (2016)
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
Regimantas Jurkus et al.
FRONTIERS IN PHARMACOLOGY (2016)
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
L. Jean-Gilles et al.
ACTA PHYSIOLOGICA (2015)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome
Shaun A. Hussain et al.
EPILEPSY & BEHAVIOR (2015)
The role of antioxidants in the chemistry of oxidative stress: A review
Aurelia Magdalena Pisoschi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis
Huan Gui et al.
IMMUNOBIOLOGY (2015)
Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria
Namrata Singh et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
Enkui Hao et al.
MOLECULAR MEDICINE (2015)
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz et al.
MOLECULAR ONCOLOGY (2015)
INVOLVEMENT OF APOPTOSIS AND CALCIUM ACCUMULATION THROUGH TRPV1 CHANNELS IN NEUROBIOLOGY OF EPILEPSY
M. Naziroglu et al.
NEUROSCIENCE (2015)
Cannabinoids and Epilepsy
Evan C. Rosenberg et al.
NEUROTHERAPEUTICS (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
J. F. C. Pedrazzi et al.
PSYCHOPHARMACOLOGY (2015)
Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models
Yunhong Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
Valerio Chiurchiu et al.
INTERNATIONAL IMMUNOLOGY (2015)
Cannabidiol enhances microglial phagocytosis via transient receptor potential ( TRP) channel activation
Samia Hassan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Cannabinoid Effects on beta Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro
Emelie Janefjord et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease
Patrick Oeckl et al.
EXPERIMENTAL NEUROLOGY (2014)
Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury
Peter S. Amenta et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Voltage-gated sodium (Nav) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se
Andrew J. Hill et al.
NEUROSCIENCE LETTERS (2014)
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis
Huan Gui et al.
RHEUMATOLOGY (2014)
Neuroanatomy of lower gastrointestinal pain disorders
Wim Vermeulen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti et al.
ONCOTARGET (2014)
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Cannabidiol as potential anticancer drug
Paola Massi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Maria Manczak et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
Maria J. Casarejos et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
M. Mecha et al.
NEUROBIOLOGY OF DISEASE (2013)
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors
M. Ruth Pazos et al.
NEUROPHARMACOLOGY (2013)
The Pharmacologic and Clinical Effects of Medical Cannabis
Laura M. Borgelt et al.
PHARMACOTHERAPY (2013)
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice
Felipe V. Gomes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
N. Rimmerman et al.
CELL DEATH & DISEASE (2013)
A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ
Yuval Ramot et al.
PEERJ (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor
Daniele Bolognini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
Ewa Kozela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
X. -H. Lin et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Neuropathic Pain Mechanisms in Patients with Chronic Sports Injuries: A Diagnostic Model Useful in Sports Medicine?
Cornelis P. van Wilgen et al.
PAIN MEDICINE (2011)
Evidence that the plant cannabinoid cannabigerol is a highly potent alpha(2)-adrenoceptor agonist and moderately potent 5HT(1A) receptor antagonist
M. G. Cascio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
J. M. Jamontt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Joel E. Schlosburg et al.
NATURE NEUROSCIENCE (2010)
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
A. Castillo et al.
NEUROBIOLOGY OF DISEASE (2010)
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
Francesca Borrelli et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
Duncan Ryan et al.
JOURNAL OF NEUROSCIENCE (2009)
Cannabidiol for the treatment of psychosis in Parkinson's disease
A. W. Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer
Zahida Qamri et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
Tamas Biro et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Inhibition of recombinant human T-type calcium channels by Δ9-Tetrahydrocannabinol and cannabidiol
Hamish Redmond Ross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression
Markus Waldeck-Weiermair et al.
JOURNAL OF CELL SCIENCE (2008)
Endogenous cannabinoids: Structure and metabolism
T. Bisogno
JOURNAL OF NEUROENDOCRINOLOGY (2008)
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons
Ning Qin et al.
JOURNAL OF NEUROSCIENCE (2008)
Nabilone for the treatment of pain in fibromyalgia
Ryan Quinlan Skrabek et al.
JOURNAL OF PAIN (2008)
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8
Luciano De Petrocellis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation
Sheona Watson et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory T cells
Venkatesh L. Hegde et al.
MOLECULAR PHARMACOLOGY (2008)
Mitochondrial fragmentation in neurodegeneration
Andrew B. Knott et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
G. Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis
Heping Xu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Attenuation of allergic contact dermatitis through the endocannabinoid system
Meliha Karsak et al.
SCIENCE (2007)
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Barbara Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis
Jonathan D. Wilkinson et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
Microglial activation and its implications in the brain diseases
S. Thameem Dheen et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Sativex®:: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
MP Barnes
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
L Weiss et al.
AUTOIMMUNITY (2006)
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
G Esposito et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
DR Blake et al.
RHEUMATOLOGY (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial
AIR Maas et al.
LANCET NEUROLOGY (2006)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
K Maresz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity
C Hamelink et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro
P Sacerdote et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
A novel synthetic, noripsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis
PF Sumariwalla et al.
ARTHRITIS AND RHEUMATISM (2004)
Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases
AC Rego et al.
NEUROCHEMICAL RESEARCH (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Cytokines and acute neurodegeneration
SM Allan et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
